4-hydroxybutyric acid has been researched along with Epilepsy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Crunelli, V; Emri, Z; Errington, AC; Gould, T; Parri, HR; Pirttimaki, T | 1 |
| Gibson, KM; Jansen, EE; Pearl, PL; Roullet, JB; Salomons, GS; Vogel, KR | 1 |
| Boenzi, S; Carducci, C; Deodato, F; Di Sabato, ML; Dionisi-Vici, C; Leuzzi, V; Liberanome, C; Malaspina, P; Rizzo, C | 1 |
3 other study(ies) available for 4-hydroxybutyric acid and Epilepsy
| Article | Year |
|---|---|
GABA(B) receptor-mediated activation of astrocytes by gamma-hydroxybutyric acid.
Topics: Animals; Astrocytes; Baclofen; Dose-Response Relationship, Drug; Epilepsy; Female; Hydroxybutyrates; Male; Mice; Mice, Knockout; Microscopy, Fluorescence; Rats; Rats, Wistar; Receptors, GABA-B; Reward; Ventral Tegmental Area; Ventral Thalamic Nuclei | 2014 |
Correlation of blood biomarkers with age informs pathomechanisms in succinic semialdehyde dehydrogenase deficiency (SSADHD), a disorder of GABA metabolism.
Topics: Adolescent; Adult; Amino Acid Metabolism, Inborn Errors; Biomarkers; Child; Child, Preschool; Developmental Disabilities; Epilepsy; Female; gamma-Aminobutyric Acid; Humans; Hydroxybutyrates; Male; Succinate-Semialdehyde Dehydrogenase; Synaptic Transmission; Young Adult | 2016 |
Vigabatrin improves paroxysmal dystonia in succinic semialdehyde dehydrogenase deficiency.
Topics: Adolescent; Brain; Brain Diseases, Metabolic; Dystonic Disorders; Epilepsy; Extremities; GABA Agents; gamma-Aminobutyric Acid; Gene Expression Regulation, Enzymologic; Humans; Hydroxybutyrates; Intellectual Disability; Italy; Male; Muscle, Skeletal; Mutation, Missense; Succinate-Semialdehyde Dehydrogenase; Treatment Outcome; Vigabatrin | 2007 |